Morgan Stanley Has Lowered Expectations for PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price
PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) had its price objective reduced by Morgan Stanley from $105.00 to $95.00 in a report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock. Several other analysts have also recently issued reports on PRCT. Wells Fargo & Company reissued an “overweight” rating and issued […]
PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) had its price objective reduced by Morgan Stanley from $105.00 to $95.00 in a report published on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock. Several other analysts have also recently issued reports on PRCT. Wells Fargo & Company reissued an “overweight” rating and issued […]